US FDA approves Pfizer, Arvinas' breast cancer drug - Reuters

4 sources covered this compare →

All sources reported the FDA approval with consistent facts, but framing varied in emphasis. Reuters and the Investing.com wire-style reports led with the regulatory milestone and clinical significance, citing the drug’s mechanism and…